1. Home
  2. SUPN vs TRMK Comparison

SUPN vs TRMK Comparison

Compare SUPN & TRMK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUPN
  • TRMK
  • Stock Information
  • Founded
  • SUPN 2005
  • TRMK 1889
  • Country
  • SUPN United States
  • TRMK United States
  • Employees
  • SUPN N/A
  • TRMK N/A
  • Industry
  • SUPN Biotechnology: Pharmaceutical Preparations
  • TRMK Major Banks
  • Sector
  • SUPN Health Care
  • TRMK Finance
  • Exchange
  • SUPN Nasdaq
  • TRMK Nasdaq
  • Market Cap
  • SUPN 1.9B
  • TRMK 2.2B
  • IPO Year
  • SUPN 2012
  • TRMK 1987
  • Fundamental
  • Price
  • SUPN $35.57
  • TRMK $38.15
  • Analyst Decision
  • SUPN Hold
  • TRMK Hold
  • Analyst Count
  • SUPN 1
  • TRMK 5
  • Target Price
  • SUPN $36.00
  • TRMK $34.60
  • AVG Volume (30 Days)
  • SUPN 422.4K
  • TRMK 354.8K
  • Earning Date
  • SUPN 11-04-2024
  • TRMK 10-22-2024
  • Dividend Yield
  • SUPN N/A
  • TRMK 2.41%
  • EPS Growth
  • SUPN 130.79
  • TRMK 111.96
  • EPS
  • SUPN 1.07
  • TRMK 3.30
  • Revenue
  • SUPN $651,972,000.00
  • TRMK $555,586,000.00
  • Revenue This Year
  • SUPN $7.82
  • TRMK N/A
  • Revenue Next Year
  • SUPN N/A
  • TRMK $3.92
  • P/E Ratio
  • SUPN $33.25
  • TRMK $11.55
  • Revenue Growth
  • SUPN 6.79
  • TRMK N/A
  • 52 Week Low
  • SUPN $25.53
  • TRMK $22.11
  • 52 Week High
  • SUPN $39.37
  • TRMK $40.60
  • Technical
  • Relative Strength Index (RSI)
  • SUPN 53.46
  • TRMK 61.89
  • Support Level
  • SUPN $35.87
  • TRMK $36.12
  • Resistance Level
  • SUPN $39.37
  • TRMK $40.60
  • Average True Range (ATR)
  • SUPN 1.69
  • TRMK 1.35
  • MACD
  • SUPN 0.03
  • TRMK 0.17
  • Stochastic Oscillator
  • SUPN 36.03
  • TRMK 64.95

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About TRMK Trustmark Corporation

Trustmark Corp is a s a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee and Texas. Its principal products and services include, Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services and others. The company is managed along three operating segments; General Banking, Wealth Management and Insurance. The General Banking segment which generates the majority of the revenue provides all traditional banking products and services, including loans, deposits and also consists of internal operations.

Share on Social Networks: